Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell Transplantation (ILD-TK01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01086735
Recruitment Status : Completed
First Posted : March 15, 2010
Last Update Posted : January 14, 2013
Sponsor:
Collaborators:
Paris 12 Val de Marne University
Pierre and Marie Curie University
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2012
Actual Study Completion Date : November 2012